PTAB Considers Discretionary Denial Based on Parallel ITC Investigation, After Withdrawal of Fintiv Memo

May 9, 2025

Reading Time : 2 min

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

The patent at issue was directed to a photosensitive device capable of detecting visible and infrared electromagnetic radiation. Petitioner filed a petition for IPR challenging the patentability of several claims. Prior to the IPR, patent owner had asserted the patent against petitioner at the ITC and in district court. The ITC investigation was ongoing, but, as is customary, the district court case was stayed pending the conclusion of the ITC investigation. Patent owner argued in the IPR that the board should deny the petition under Fintiv because institution would incur significant inefficiencies and risk inconsistent outcomes. The board analyzed each of the six Fintiv factors in turn.

The board determined that factors two, three, and five weighed in favor of discretionary denial.  In reaching that finding, the board noted that the ITC investigation had a target completion date more than three months before the statutory deadline for a final written decision in the IPR, the ITC had already completed substantial work, and the parties were the same in the IPR and the ITC investigation. Factor one—whether there is a stay in the parallel proceedings—was neutral. Although there was a stay in the district court, there was no stay for the ITC investigation. The board noted that the lack of a stay for the ITC investigation elevated the importance of factor four, which concerns overlap between issues raised in the petition and parallel proceedings.

Regarding factor four, patent owner initially argued that the validity issues presented were nearly identical at the PTAB and in the ITC. Petitioner responded by withdrawing a ground from the IPR petition that overlapped with the ITC investigation and stipulating that “if the [b]oard institutes this IPR on the two remaining applicable grounds, petitioner will not assert invalidity in parallel litigation using as primary or combination references any of the references asserted in those grounds.” The board thereafter determined that the record no longer supported that the ITC would adjudicate the invalidity grounds raised in the petition and therefore factor four weighed against discretionary denial. The board also determined that “other considerations” under factor six weighed against denial, including that the petition’s merits were strong and that the narrowing of the petition minimized the burden on the parties and the board. 

In considering the factors as a whole, the board ultimately concluded that the strength of the merits and lack of overlap in proceedings outweighed any potential inefficiencies and declined to exercise its discretion in this situation.

Practice Tip:

In light of the withdrawal of the June 21, 2022 Fintiv Memo, patent owners faced with an IPR should now consider arguing for discretionary denial under Fintiv where there is a parallel ITC investigation.  Conversely, petitioners seeking to avoid discretionary denial should consider taking steps to minimize overlap between unpatentability grounds in a petition and invalidity positions taken in parallel proceedings.


Samsung Elecs. Co., Ltd. v. Sionyx, LLC, IPR2024-01431, Paper 21 (P.T.A.B. Apr. 10, 2025)

Share This Insight

Previous Entries

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

IP Newsflash

April 23, 2025

The Federal Circuit recently refused to apply collateral estoppel to claims of a patent asserted in district court litigation based on a Patent Trial and Appeal Board (PTAB) decision finding similar claims from the same patent unpatentable because the PTAB applied a lower burden of proof than what is required to invalidate claims in district court.

...

Read More

IP Newsflash

April 7, 2025

The Central District of California denied a defendant’s motion to dismiss or transfer plaintiff’s first-filed declaratory judgment action based on defendant’s later-filed patent infringement suit in Wisconsin.  Though suit was seemingly imminent when defendant advised plaintiff it might be infringing defendant’s patents, plaintiff responded by requesting a licensing agreement in lieu of litigation. The court found that plaintiff’s action was not anticipatory forum-shopping litigation because plaintiff only filed suit after defendant neglected to respond to its licensing offer.

...

Read More

IP Newsflash

April 1, 2025

The District of Delaware recently denied in part a motion to compel production of documents and testimony between a patentee and potential investors, valuation firms and an international bank based on the common interest exception. In so doing, the court reaffirmed that disclosure of privileged information to third parties will generally waive privilege unless it can be shown that the parties’ interests are identical and the communications are legal, not solely commercial.

...

Read More

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.